Fortrea slips after new CFO appointment
BUZZ-Fortrea slips after new CFO appointment ** Shares of Fortrea Holdings Inc FTRE.O fell ~2% to $17.35 before the bell
** The contract research organization appoints Jason Knoblauch CFO, effective July 6
** Knoblauch succeeds Jill McConnell, who has held the role since the company's July 2023 spinoff from Labcorp LH.N
** Knoblauch was most recently CFO at Clario, a provider of endpoint data solutions to the clinical trials industry
** FTRE reiterates its guidance for the full year 2026
** YTD, the stock has risen 2.67%
(Reporting by Krisha Bhatt in Bengaluru)
Recent news on Fortrea Holdings
See all newsFortrea Q3 revenue beats expectations on bookings momentum, guidance raised
Brief: Fortrea And Omico Collaboration To Advance Biomarker-Led Oncology Drug Development
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler
Brief: Fortrea Completes Acquisition Of The Early Phase Services Division From Worldwide Clinical Trials
US RESEARCH ROUNDUP-Acuity, Dell Technologies, Nike